TCTR20200107003已完成不适用
Drug patch testing in cutaneous drug allergic patient
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- one
- 入组人数
- 122
研究概览
简要总结
We recommend drug patch testing as a safe method to identify the culprit drug in CADRs especially DRESS, MP, and FDE. The positive drug patch test results may depend on the clinical presentation together with drug categories and duration of time to perform patch testing. In HIV patients, the positive test was associated with low CD4 count and co-positive reaction.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Patient with cutaneous drug eruption including all delayed type drug eruption
- •3 Morbiliform drug rash
- •4 lichenoid drug eruption
- •5 fixed drug eruption
排除标准
- •Patient with immunosuppressive agent
- •Patient with immediated type drug hypersensitivity such as urticaria and anaphylaxia
研究者
相似试验
Unknown
不适用
Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)Drug ReactionNCT03176342Chulalongkorn University30
招募中
不适用
Diagnosing Drug Allergy: the T is the KeyAmoxicillin AllergyNCT06409884University Hospital, Antwerp300
已完成
早期 1 期
Efficacy of Baricitinib In Treatment of Delayed-Type Hypersensitivity Versus Irritant Skin Reactions in Healthy Adult Male SubjectsAllergic Contact DermatitisNCT03945760Wright State Physicians23
已完成
1 期
A Safety Study to Investigate the Skin Sensitization Potential of MFC51123PainNCT02192203GlaxoSmithKline227
招募中
不适用
Patient Experience and Quality of Patch Testing on the Legs vs BackAllergic Contact DermatitisNCT06191627HealthPartners Institute30